EGFR and non-small cell lung carcinoma: The safety and effectiveness of BLU-701 in patients with EGFR-mutated NSCLC who have received previous treatment with EGFR TKIs is currently being assessed in the phase I/II HARMONY trial (NCT05153408) [203].